Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin B12 Supplementation in Infants (RART)
NCT05005897Phase 3Recruiting
- Sponsor
- Sykehuset Innlandet
- Start
- Dec 2021
- Primary completion
- Oct 2025
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
A Phase 3 trial of cyanocobalamin in vitamin B12 deficiency, sponsored by Sykehuset Innlandet. Started Dec 2021; status: recruiting.
02
Drugs
cyanocobalamin
03
Conditions
vitamin B12 deficiency
Beyond the preview
Go deeper on NCT05005897.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05005897.